1. Development of radioimmunotherapeutic and diagnostic antibodies: an inside–out view;Boswell;Nucl Med Biol,2007
2. Different ways to improve the clinical effectiveness of radioimmunotherapy in solid tumors;Chatal;J Cancer Res Ther,2009
3. Antibody pretargeting advances cancer radioimmunodetection and radioimmunotherapy;Goldenberg;J Clin Oncol,2006
4. An alternative pretargeting technology that so far has not been validated in the clinic uses the hybridization of DNA and its analogs: Liu GZ, Mang'era K, Liu N, Gupta S, Rusckowski M, Hnatowich D J. Tumor pretargeting in mice using Tc-99m-labeled morpholino, a DNA analog. J Nucl Med 2002;43:384-391; Kuijpers WHA, Bos ES, Kaspersen FM, Veeneman GH, Vanboeckel, CAA. Specific recognition of antibody oligonucleotide conjugates by radiolabeled antisense nucleotides — a novel approach for 2-step radioimmunotherapy of cancer. Bioconjugate Chem. 1993;4:94-102.
5. Cell surface engineering by a modified Staudinger reaction;Saxon;Science,2000